Clinical trials in Somerset, NJ

10 recruiting studies have a site in or near Somerset, NJ, New Jersey.

Top conditions here

All conditions

Showing 10 of 10 studies

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Bridgewater, NJ · Linden, NJ · Somerset, NJ · +205 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Bridgewater, NJ · Jersey City, NJ · Somerset, NJ · +163 more sites

RecruitingPhase 3NCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Sponsor: Amgen

Somerset, NJ · +139 more sites

RecruitingPhase 3NCT07776509

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Somerset, NJ · +22 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

Eatontown, NJ · Somerset, NJ · Warren Township, NJ · +51 more sites

RecruitingPhase 3NCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Sponsor: Amgen

Bridgewater, NJ · Marlton, NJ · Newark, NJ · +118 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Eatontown, NJ · Pennington, NJ · Somerset, NJ · +195 more sites

RecruitingPhase 3NCT07567001

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Sponsor: Novo Nordisk A/S

Elmer, NJ · Hackettstown, NJ · Haddon Heights, NJ · +203 more sites

RecruitingPhase 2NCT05806931

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Sponsor: Rutgers, The State University of New Jersey

Elizabeth, NJ · Jersey City, NJ · Lakewood, NJ · +6 more sites

RecruitingPhase 2NCT05559164

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Sponsor: Rutgers, The State University of New Jersey

Elizabeth, NJ · Hamilton, NJ · Jersey City, NJ · +7 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.